AstraZeneca's China Executive Detained Amid Drug Import Investigation

Leon Wang's arrest raises concerns about foreign business operations in China as authorities probe alleged illegal activities.

Leon Wang, head of AstraZeneca's China operations, has been detained by Chinese authorities in Shenzhen.
The detention is linked to investigations into alleged illegal drug imports and potential data privacy violations.
AstraZeneca's shares fell amid investor concerns, though the company asserts the investigation is separate from an earlier insurance fraud case.
The pharmaceutical giant emphasizes its ongoing cooperation with Chinese authorities and commitment to its operations in the country.
China remains a crucial market for AstraZeneca, contributing significantly to its global sales despite recent challenges.